Skip Navigation
Medical University | MUSC Hospital | Directory | A-Z Index

MUSC logo

ART

   | MUSC Medical Center Residency Program | Programs | PGY2 | Drug Information Practice

Drug Information Practice

Kelli Garrison, PharmD, BCPS
Manager, Medication Use Policy & Informatics
Residency Program Director

For a complete description of the PGY2 Drug Information program (eg, outcomes, learning experiences, preceptors, selection of candidates), please click HERE.

Introduction:

The Medical University of South Carolina Medical Center is a tertiary teaching hospital that serves the colleges of medicine, dentistry, nursing, allied health, and pharmacy. The Medication Policy and Informatics division of the Department of Pharmacy Services incorporates 3 separate work groups including Drug Information Services, Information Systems, and Outcomes Management. For this residency program, the resident will participate in all three areas with the main focus on the Drug Information Service. 

The goal of the Drug Information Service is to provide accurate, unbiased drug information that is directly applicable to patient care.  The service participates in formulary management in collaboration with the pharmacy and Therapeutics Committee. It also provides a call center for healthcare professionals and consumers. The Drug Information Center is staffed by drug information specialists, residents, and students, and answers approximately 1700 requests per year.  In addition to over 350 major medical reference texts, available drug information resources include MICROMEDEX® Healthcare Series, Facts and Comparisons Online 4.0, and International Pharmaceutical Abstracts. Access to computerized databases and on-line literature searching is also available within the Drug Information Center. The MUSC Library, located nearby within the Medical Center complex, provides access to over 74,000 books including 735 e-books, over 15,000 e-journals and 70 print-only subscriptions, and 100 databases including MEDLINE, CINAHL, and PsycINFO.

Purpose:

The Postgraduate Year Two (PGY2) Drug Information Residency Program is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. The Drug Information Residency Program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident’s ability to provide care in the most complex of cases or in the support of care through practice leadership. Therefore, Drug Information Programs provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. 

This specialty residency is designed to develop practitioners who possess an expert level of competency in drug information practice. The program allows sufficient flexibility to adapt to the individual needs of the resident, while ensuring that all ASHP standards for drug information specialized residency training are met. Upon completion of this program, the resident will be prepared to enter a variety of positions related to drug information practice. A resident who successfully completes an accredited PGY2 Drug Information Pharmacy Residency should possess the skills needed to excel in the following positions: clinical specialist in Drug Information, Drug Information faculty member, director of Drug Information Services, or similar area, medical writer or editor,
or medical science liaison.  Additionally, upon completion of the PGY2 program, the resident should possess competencies that enable attainment of board certification, ie, BCPS.

 


On-site Interviews Will Be Required


Starting in 2012 the MUSC Pharmacy Program will be using the PhORCAS Application System through ASHP.  Please submit all application materials through the applicant portal on ASHP's website.  The deadline for receipt of a complete application packet is December 31st.  Applicants can begin submitting materials through PhORCAS on November 19.  Complete applications include the following:

  • Letter of intent (uploaded with application)
  • Curriculum vitae (uploaded with application)
  • Three letters of reference completed by health professionals who can attest to the applicant’s practice abilities and aptitudes (uploaded directly from the authors beginning on November 19)
  • At least one letter must be from an immediate supervisor (if applicable - for PGY1 only)
  • At least one letter must be from a clinical preceptor
  • Official transcripts of all professional pharmacy education
  • Class rank (in a sealed envelope from Dean's Office)
  • List of Rotations completed.

The application, letter of intent and curriculum vitae should be submitted via the PhORCAS applicant portal.  Letters of reference should also be submitted via PhORCAS Reference Portal using the ASHP Reference Template no later than December 31 directly from the authors.  For further information, please see application information.

For further information contact:
Residency Program Director
Kelli L. Garrison, PharmD, BCPS
Manager, Medication Use Policy & Informatics
Phone: (843) 792-4682
Fax: (843) 792-5532
Email:
garrisok@musc.edu

Introduction|Purpose|Outcomes|The Residency Experience|Learning Experiences

 

August 5, 2014
 
MUSC Residency In The News
Schedules
Resident Seminar
RITE, Current Topics & Discussion Series
Quick Links
Who's On What (WOW)

Alumni & Resident Newsletter